Venture · Pre-IPO · Public markets · Credit
Investing from first principles.
- Technology · Life sciences
- Early stage to IPO
- Tickets up to US$10M
17z invests in technology and life sciences across venture, pre-IPO, public and private equity, and credit.
01
We invest in computing that makes hard problems tractable and medicine that helps people live longer, healthier lives.
Every position begins with the fundamentals: the physics of the technology, the economics of the business, and the durability of its advantage. We look for companies whose products compound over decades, and we hold them with conviction in whatever form of capital fits best.
Our own work
Theses are built from primary evidence and fundamental analysis rather than consensus, and revised without ego when the facts change.
Technology that endures
The infrastructure and platforms of the coming decades: computing, AI, and the systems the modern economy runs on.
Medicine that matters
Therapies, devices, and diagnostics that measurably extend and improve human life.
02
Across the full arc
of a company’s life.
We invest where the opportunity is best expressed, from a company’s early rounds to its life as a listed business, in equity or in credit.
Venture and early stage
Early conviction in founders solving hard problems, with capital and patience through the formative years.
Late stage and pre-IPO
Positions in category leaders as they approach the public markets, through primary and secondary rounds.
Public and private equity
Concentrated ownership in exceptional businesses, listed or private, held with a long-term owner’s mindset.
Credit and structured debt
Senior, structured, or opportunistic credit when debt serves the company better than equity, with terms and protections that fit the risk.
03
How we work.
Direct, flexible, and patient. What founders and co-investors can expect when we invest:
- Ticket sizeUp to US$10MSized to conviction and to what the round needs.
- StageEarly stage to IPOFrom early rounds through pre-IPO, and in the public markets.
- InstrumentEquity or structured debtWhichever form of capital fits the company best.
- TimelineSet by the dealNot by a committee calendar. We move as quickly as the work allows.
- HorizonA long-term partnerPatient capital that holds through cycles.
A concentrated portfolio across technology and life sciences.
04
Get in touch.
We read every message.
Founders
Share a short overview of the company, or a link to your deck.
Investors and others
A few lines on who you are and what you have in mind is plenty.